PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Axorid 200mg/20mg modified-release capsules
1001010L0BQABAN
Axorid Ketoprofen Musculoskeletal and Joint Diseases No data available
Aybintio 100mg/4ml solution for infusion vials
0801050APBDAAAA
Aybintio Bevacizumab Malignant Disease and Immunosuppression No data available
Aybintio 400mg/16ml solution for infusion vials
0801050APBDABAB
Aybintio Bevacizumab Malignant Disease and Immunosuppression No data available
Aymes Actagain Protein Shot Starter Pack
0913141A0BCABAE
Aymes RtS 1.4-1.5kcal/ml energy and higher protein liquid RtS 1.4-1.5kcal/ml energy & higher protein liquid (0913141) Nutrition and Blood No data available
Aymes Acusist Clear Instant Thickener powder
0913411A0BBAAAA
Aymes powder disc or non ACBS thickener - gum based Powder disc or non ACBS thickener - gum based (0913411) Nutrition and Blood No data available
Aymes oral powder 38g sachets banana
0913311A0BBAAAA
Aymes powder OTC ONS Powder OTC ONS (0913311) Nutrition and Blood No data available
Aymes oral powder 38g sachets chocolate
0913311A0BBABAA
Aymes powder OTC ONS Powder OTC ONS (0913311) Nutrition and Blood No data available
Aymes oral powder 38g sachets strawberry
0913311A0BBACAA
Aymes powder OTC ONS Powder OTC ONS (0913311) Nutrition and Blood No data available
Aymes oral powder 38g sachets vanilla
0913311A0BBADAA
Aymes powder OTC ONS Powder OTC ONS (0913311) Nutrition and Blood No data available
Aymes oral powder 49g sachets chicken
090402000BBXKA0
Proprietary compound enteral nutrition Enteral nutrition Nutrition and Blood No data available
Aymes Shake powder 57g sachets chicken
0913011C0BBABAH
Aymes powder 1.6 kcal/ml milkshake Powder 1.6 kcal/ml milkshake (0913011) Nutrition and Blood No data available
Azacitidine 100mg powder for suspension for injection vials
0801030ACAAAAAA
Azacitidine Azacitidine Malignant Disease and Immunosuppression No data available
Azacitidine 150mg powder for suspension for injection vials
0801030ACAAACAC
Azacitidine Azacitidine Malignant Disease and Immunosuppression No data available
Azactam 1g powder for solution for injection vials
0501023A0BBABAB
Azactam Aztreonam Infections No data available
Azactam 2g powder for solution for injection vials
0501023A0BBAAAA
Azactam Aztreonam Infections No data available
Azactam 500mg powder for solution for injection vials
0501023A0BBACAC
Azactam Aztreonam Infections No data available
Azapropazone 300mg capsules
1001010B0AAAAAA
Azapropazone Azapropazone Musculoskeletal and Joint Diseases No data available
Azapropazone 600mg tablets
1001010B0AAABAB
Azapropazone Azapropazone Musculoskeletal and Joint Diseases No data available
Azatadine 500micrograms/5ml oral solution
0304010C0AAAAAA
Azatadine maleate Azatadine maleate Respiratory System No data available
Azathioprine 100mg/5ml oral solution
0802010G0AAAVAV
Azathioprine Azathioprine Malignant Disease and Immunosuppression No data available
Azathioprine 10mg/5ml oral liquid
0802010G0AAARAR
Azathioprine Azathioprine Malignant Disease and Immunosuppression No data available
Azathioprine 120mg/5ml oral liquid
0802010G0AABXBX
Azathioprine Azathioprine Malignant Disease and Immunosuppression No data available
Azathioprine 125mg/5ml oral liquid
0802010G0AAAXAX
Azathioprine Azathioprine Malignant Disease and Immunosuppression No data available
Azathioprine 12mg/5ml oral liquid
0802010G0AABSBS
Azathioprine Azathioprine Malignant Disease and Immunosuppression No data available
Azathioprine 13mg/5ml oral liquid
0802010G0AACECE
Azathioprine Azathioprine Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.